ESR1 and triple-negative breast carcinoma: Among these subgroups, triple-negative breast cancer (TNBC), which is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and Her2/neu receptor expression has the poorest prognosis and accounts for approximately 10% of all breast cancer cases5,6.